(Q43775256)
Statements
1 reference
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test (English)
1 reference
Laine K
1 reference
Tybring G
1 reference
Härtter S
1 reference
Andersson K
1 reference
Svensson JO
1 reference
Widén J
1 reference
Bertilsson L
1 reference
1 October 2001
1 reference
1 reference
Identifiers
1 reference